Marine-Derived Compounds in Metabolic Regulation and Chronic Disease
A special issue of Marine Drugs (ISSN 1660-3397). This special issue belongs to the section "Marine Pharmacology".
Deadline for manuscript submissions: 15 August 2026 | Viewed by 708
Special Issue Editor
Interests: marine natural products; bioactive compounds; bioactive peptides; chronic disease modulation; tissue regeneration
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Metabolic dysregulation underlies many chronic diseases, including type 2 diabetes, obesity, non-alcoholic fatty liver disease, and cardiovascular disorders. The discovery of novel agents capable of restoring metabolic homeostasis therefore represents a critical research frontier. Marine organisms, with their unique chemical diversity, are a prolific source of bioactive compounds—such as polysaccharides (e.g., fucoidan, alginate), peptides, omega-3 fatty acids, carotenoids (e.g., fucoxanthin, astaxanthin), polyphenols, and microbial metabolites—that offer promising mechanisms in interacting with diverse biological target sites and regulating key pathways involved in metabolic health and disease progression.
This Special Issue aims to compile cutting-edge research on the role of marine-derived compounds in metabolic regulation and their potential in preventing or treating chronic metabolic diseases. We welcome original research articles and reviews focusing on the identification, characterization, molecular mechanisms, and therapeutic efficacy of these marine bioactives in metabolic disease intervention.
Prof. Dr. Jae-Young Je
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- marine
- natural products
- metabolic regulation
- metabolic syndrome
- chronic disease
- molecular mechanisms
- bioactive
- therapeutics
- pathways
- nutraceuticals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
